Showing results (41-50 of 123) with videos related to
Sort By:
Pageof 13
European Journal of Pharmacology|April 20, 2024
Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphorylation immunoassayNina K Blum, Anne Schaffner, Julia Drube, et al.Pediatric Nephrology (Berlin, Germany)|June 29, 2016
Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center studyThurid Ahlenstiel-Grunow, Nele K Kanzelmeyer, Kerstin Froede, et al.The Journal of Biological Chemistry|December 31, 2025
GRK phosphorylation drives β-arrestin-independent internalization of chemokine receptor CXCR5Joseph M Crecelius, Ya Zhuo, Aaren R Manz, et al.Plos One|April 6, 2021
Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthmaCarolin Boehne, Ann-Kathrin Behrendt, Almut Meyer-Bahlburg, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2017
The p38-MK2/3 Module Is Critical for IL-33-Induced Signaling and Cytokine Production in Dendritic CellsChristiane Göpfert, Nico Andreas, Franziska Weber, et al.Physical Review Letters|June 13, 2002
Quadrupolar transitions evidenced by resonant auger spectroscopyJ Danger, P Le Fèvre, H Magnan, et al.Experimental Dermatology|September 14, 2016
Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiationMandy Leist, Cathleen Annett Sünder, Sebastian Drube, et al.The Review of Scientific Instruments|November 29, 2014
Bulk sensitive hard x-ray photoemission electron microscopyM Patt, C Wiemann, N Weber, et al.European Journal of Immunology|February 3, 2011
PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcomeLuciana Berod, Christina Heinemann, Sylvia Heink, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2010
De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantationL Pape, G Offner, M Kreuzer, et al.Pageof 13